Childhood Cancer Data Initiative Annual Symposium (Abstract Registration): Submission #83
Submission information
Submission Number: 83
Submission ID: 193782
Submission UUID: ce8c5218-fc94-40e1-b0a2-67ebb733e588
Submission URI: /nci/ccdisymposium/abstract
Created: Thu, 09/03/2026 - 19:43
Completed: Thu, 09/03/2026 - 19:48
Changed: Thu, 09/03/2026 - 19:48
Remote IP address: 10.208.24.244
Submitted by: Anonymous
Language: English
Is draft: No
| Abstract Title: | Single-Cell Multiome Sequencing Reveals Distinct Transcriptional Programs Associated with ecDNA Amplifications in Medulloblastoma |
|---|---|
| Abstract: | Extrachromosomal DNA (ecDNA) is a key driver of intratumoral heterogeneity and has been linked to therapeutic resistance and poor patient outcomes. However, technical limitations in identifying, isolating, and analyzing ecDNA at the single-cell level have hindered our understanding of its role in tumor development and treatment response. We have previously developed a single-cell multiome (RNA + ATAC) sequencing approach that enables the simultaneous analyses of ecDNA and its gene expression profiles. Initial application of this method in a medulloblastoma tumor of the sonic hedgehog subgroup revealed distinct transcriptional signatures in ecDNA-positive compared to ecDNA-negative and non-malignant cells. Building on these findings, we performed single-cell multiome sequencing on an additional cohort of medulloblastoma specimens harboring ecDNA amplifications, obtained from Rady Children's Hospital and the Children's Brain Tumor Network (CBTN). Initial analyses revealed distinct functional characteristics between ecDNA-positive and ecDNA-negative tumor cells. For example, ecDNA-positive tumor cells show up-regulation of DNA replication, recombination, and damage repair pathways, while ecDNA-negative cells demonstrated increased expression of synaptic activity, cell signaling, and morphogenesis pathways. Our ongoing analysis focuses on further defining the transcriptional programs that distinguish ecDNA-positive from ecDNA-negative tumor cells, ultimately informing future functional genetic and pharmacological studies targeting transcriptional dependencies in ecDNA-driven medulloblastoma tumors. |
| Authors: |
|
| Presenting Author: | Hui Hui |
| Institution: | Sanford Burnham Prebys Medical Discovery Institute |
| Email Address: | ahui@sbpdiscovery.org |